Get the up-to-date omb no 0910 0014 form-2024 now

Get Form
0014 Preview on Page 1

Here's how it works

01. Edit your clinical statement of health form online
01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

The easiest way to modify Omb no 0910 0014 form in PDF format online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

Adjusting paperwork with our comprehensive and user-friendly PDF editor is straightforward. Adhere to the instructions below to complete Omb no 0910 0014 form online quickly and easily:

  1. Sign in to your account. Log in with your email and password or create a free account to test the service before upgrading the subscription.
  2. Upload a document. Drag and drop the file from your device or add it from other services, like Google Drive, OneDrive, Dropbox, or an external link.
  3. Edit Omb no 0910 0014 form. Quickly add and highlight text, insert pictures, checkmarks, and signs, drop new fillable fields, and rearrange or delete pages from your document.
  4. Get the Omb no 0910 0014 form completed. Download your modified document, export it to the cloud, print it from the editor, or share it with other participants through a Shareable link or as an email attachment.

Take advantage of DocHub, the most straightforward editor to quickly handle your paperwork online!

See more omb no 0910 0014 form versions

We've got more versions of the omb no 0910 0014 form form. Select the right omb no 0910 0014 form version from the list and start editing it straight away!
Versions Form popularity Fillable & printable
2019 4.9 Satisfied (21 Votes)
2016 4.4 Satisfied (225 Votes)
2013 4.3 Satisfied (81 Votes)
2006 4 Satisfied (54 Votes)
be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
The first is to provide the sponsor with the investigators qualifications and information about the clinical site. In summary, the first purpose is to inform the sponsor that the investigator is qualified, and the clinical site is an appropriate location for clinical investigation.
For a sponsor-investigator IND, the sponsor-investigator should be named and must sign the form. For an IND sponsored by a pharmaceutical firm or research organization, the name of the sponsors authorizing representative should be entered and that individual must sign the form.
The Statement of Investigator (Form FDA 1572) is a form that is required to be filled for clinical trials involving investigational drugs or biologics.
The Statement of Investigator, Form FDA 1572, is a document that must be completed and signed by the lead investigator for each clinical investigation conducted under an Investigational New Drug Application (IND).
Completing Form FDA 1572 The investigators full legal name (e.g., name on the investigators birth certificate or marriage certificate) must be used. The work address where the investigator can be docHubed by mail or in person should be entered. An administrative room number within a building must be included.
be ready to get more

Complete this form in 5 minutes or less

Get form

People also ask

Explanation: Accuracy on FDA Form 1572 is essential since it serves as an agreement between investigational sites and the Food Drug Administration (FDA).
The revised draft guidance clarifies that if a non-U.S. investigator cannot or will not sign the investigator statement (e.g., because regional, national, or local laws or regulations prohibit its signing), the revised guidance clarifies that a sponsor may submit a request for a waiver of the 1572 signature requirement
The Statement of Investigator, Form FDA 1572, is a document that must be completed and signed by the lead investigator for each clinical investigation conducted under an Investigational New Drug Application (IND).
provide certain information to the Sponsor about the Principal Investigators qualifications and the clinical site. appropriate location at which to conduct the clinical investigation. regulations related to the conduct of a clinical investigation of an investigational drug or biologic.
Form FDA 1571: Coversheet for all IND submissions. The 1571 must be signed by the Sponsor of the IND. Form FDA 1572: Statement of Investigator. The 1572 must be signed by the Principal Investigator of the clinical trial.

Related links